[ORGANIZATION]
Nivolumab
Featured in 3 tracked stories · first seen
Situations
Replimune melanoma therapy FDA approval
3 clusters · 18 sources · last updated
Latest: FDA approves new oncolytic viral therapy for anti‑PD‑1‑refractory melanoma
Following the FDA’s Cellular, Tissue and Gene Therapies Advisory Committee vote of 10‑3 in late July 2026, the agency granted accelerated approval on 6 August 2026 to Replimune’s oncolytic herpes‑virus therapy RP1, marke
Brazil cancer drug access crisis
2 clusters · 3 sources · last updated
Latest: Brazilian Cancer Patients Face Drug Shortage and Funding Crisis
In late July 2026, reports highlighted extreme financial barriers for Brazilian children with serious cancers, including a 10‑year‑old needing a R$3 million bone‑marrow transplant drug and a 7‑year‑old receiving palliati